Long-term use of benzodiazepines and nonbenzodiazepine hypnotics, 1999-2014.
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Clinical guidelines suggest that benzodiazepines (BZDs) and non-BZD hypnotics (NBHs) be used on a short-term basis. The authors examined trends in long-term BZD and NBH use from 1999 to 2014. METHODS: Data included 82,091 respondents in the 1999-2014 waves of the National Health and Nutrition Examination Survey (NHANES). NHANES recorded medications used in the past 30 days on the basis of prescription bottles, and participants reported use duration. BZD and NBH use were categorized as short, medium, and long term, and time trends in use were assessed. RESULTS: BZD and NBH use increased from 1999 to 2014, driven by increases in medium- and long-term use, even after adjustment for age and race-ethnicity. In most years, only a fifth of current BZD or NBH users reported short-term use. CONCLUSIONS: Long-term BZD and NBH use has grown independent of U.S. demographic shifts. Monitoring of use is needed to prevent adverse outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“a lack of access to CBTi has resulted in the majority of insomnia sufferers receiving prescriptions for sedative-hypnotic medications as the initial and ongoing treatment [12,13].”
From Co-morbid insomnia and sleep apnea (COMISA): Prevalence, consequences, methodological considerations, and recent randomized controlled trials (2019) · cites this paper as [13]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Other studies using pharmaceutical claims data and the National Health and Nutrition Examination Survey support the conclusion that long-term benzodiazepine use may be a larger driver of the increased use of this class of medications.23,24”
From Patterns in Outpatient Benzodiazepine Prescribing in the United States (2019) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
Qaseem, A., Kansagara, D., Forciea, M. A., Cooke, M., Denberg, T. D., & for the Clinical Guidelines Committee of the American College of Physicians* (2016) · Annals of Internal Medicine · doi:10.7326/m15-2175 · Cited by 1,965 · cited 1×
“In recently published treatment guidelines for chronic insomnia, the American College of Physicians recommended that these medications be used only on a short-term basis and only if behavioral treatments alone are ineffective (8).”
BackgroundBenzodiazepine Use in the United States
Olfson, M., King, M., & Schoenbaum, M. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1763 · Cited by 786
Pharmaceutical Overdose Deaths, United States, 2010
Jones, C. M., Mack, K. A., & Paulozzi, L. J. (2013) · JAMA · doi:10.1001/jama.2013.272 · Cited by 678
National Use of Prescription Medications for Insomnia: NHANES 1999-2010
Bertisch, S. M., Herzig, S. J., Winkelman, J. W., & Buettner, C. (2014) · Sleep · doi:10.5665/sleep.3410 · Cited by 305 · cited 2×
“(12), which used National Health andNutrition Examination Survey (NHANES) data; the authors found an increase in the prevalence of use of insomnia medications from 1999 to 2010.”
BackgroundMethodWilt, T. J., MacDonald, R., Brasure, M., Olson, C. M., Carlyle, M., Fuchs, E., Khawaja, I. S., Diem, S., Koffel, E., Ouellette, J., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1781 · Cited by 275 · cited 1×
“Concerns that long-term use may be associated with adverse outcomes (6) have prompted guidelines recommending use of these medications on a short-term basis (6,7).”
BackgroundZolpidem Use and Hip Fractures in Older People
Wang, P. S., Bohn, R. L., Glynn, R. J., Mogun, H., & Avorn, J. (2001) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2001.49280.x · Cited by 272 · cited 2×
“Studies show increased prescribing of medications commonly used for treatment of anxiety and sleep disorders, specifically benzodiazepines (BZDs) and non-BZD hypnotics (NBHs), since the early 1990s (1,2), despite concerns about adverse health outcomes associated with their use (3,4).”
BackgroundMojtabai, R., & Olfson, M. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08443 · Cited by 247 · cited 1×
“On the basis of a previous study (13), we categorized length of use into short term (less than six months), medium term (six to 24 months), and long term (more than 24 months).”
MethodSelf-citationFord, E. S., Wheaton, A. G., Cunningham, T. J., Giles, W. H., Chapman, D. P., & Croft, J. B. (2014) · Sleep · doi:10.5665/sleep.3914 · Cited by 213 · cited 2×
“Studies show increased prescribing of medications commonly used for treatment of anxiety and sleep disorders, specifically benzodiazepines (BZDs) and non-BZD hypnotics (NBHs), since the early 1990s (1,2), despite concerns about adverse health outcomes associated with their use (3,4).”
BackgroundTrends in prescribing of sedative-hypnotic medications in the USA: 1993-2010.
Kaufmann, C. N., Spira, A. P., Alexander, G. C., Rutkow, L., & Mojtabai, R. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3951 · Cited by 105 · cited 4×
“Studies show increased prescribing of medications commonly used for treatment of anxiety and sleep disorders, specifically benzodiazepines (BZDs) and non-BZD hypnotics (NBHs), since the early 1990s (1,2), despite concerns about adverse health outcomes associated with their use (3,4).”
BackgroundMethodInfluentialThe Future of Cognitive Behavioral Therapy for Insomnia: What Important Research Remains to Be Done?
Vitiello, M. V., McCurry, S. M., & Rybarczyk, B. D. (2013) · Journal of Clinical Psychology · doi:10.1002/jclp.21948 · Cited by 58 · cited 2×
“There is ample evidence supporting efficacy of behavioral treatments for insomnia and anxiety disorders (15).”
BackgroundRossat, A., Fantino, B., Bongue, B., Colvez, A., Nitenberg, C., Annweiler, C., & Beauchet, O. (2011) · The Journal of nutrition, health and aging · doi:10.1007/s12603-011-0015-7 · Cited by 43 · cited 2×
“Studies show increased prescribing of medications commonly used for treatment of anxiety and sleep disorders, specifically benzodiazepines (BZDs) and non-BZD hypnotics (NBHs), since the early 1990s (1,2), despite concerns about adverse health outcomes associated with their use (3,4).”
BackgroundContinuing Versus New Prescriptions for Sedative-Hypnotic Medications: United States, 2005–2012
Kaufmann, C. N., Spira, A. P., Depp, C. A., & Mojtabai, R. (2016) · American Journal of Public Health · doi:10.2105/ajph.2016.303382 · Cited by 33 · cited 1×
“, refills), rather than new prescriptions for these medications, are driving the growing trends in their prescribing, suggesting an increase in the long-term use of these medications (10).”
Background
Research works printed but not linked: 2
- National Institute for Health and Care Excellence Generalised anxiety disorder and panic disorder in adults: management [Internet] 2011 Available from: https://www.nice.org.uk/guidance/cg113/resources/generalised-anxiety-disorder-and-panic-disorder-in-adults-management-pdf-35109387756997 31961629
- Ortman JM Velkoff VA An aging nation: the older population in the United States Washington 2014
Cited by
Benzodiazepine Use and Misuse Among Adults in the United States
Maust, D. T., Lin, L. A., & Blow, F. C. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201800321 · Cited by 337
Patterns in Outpatient Benzodiazepine Prescribing in the United States
Agarwal, S. D., & Landon, B. E. (2019) · JAMA Network Open · doi:10.1001/jamanetworkopen.2018.7399 · Cited by 319
Benzodiazepines I: Upping the Care on Downers: The Evidence of Risks, Benefits and Alternatives
Guina, J., & Merrill, B. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7020017 · Cited by 253
“Total BZD use actually increased from 1999 to 2014, largely driven by increases in long-term use [16].”
BackgroundSweetman, A., Lack, L., & Bastien, C. (2019) · Brain Sciences · doi:10.3390/brainsci9120371 · Cited by 253
“Although cognitive and behavioral therapy for insomnia (CBTi) leads to long-term improvement of insomnia and is the recommended ‘first line’ insomnia treatment [8–11], a lack of access to CBTi has resulted in the majority of insomnia sufferers receiving prescriptions for sedative-hypnotic medications as the initial an…”
BackgroundRecent advances in synthesis and medicinal chemistry of benzodiazepines
Arora, N., Dhiman, P., Kumar, S., Singh, G., & Monga, V. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103668 · Cited by 114
Metadata
- Authors
- Kaufmann, C. N., Spira, A. P., Depp, C. A., & Mojtabai, R.
- Affiliations
- Johns Hopkins University (US)
- Venue
- Psychiatric Services
- Published
- 2018-02-01
- Volume
- 69
- Issue
- 2
- Pages
- 235-238
- ISSN
- 0022-1597 (ISSN-L)
- 1075-2730
- 1557-9700
- PMC
- PMC5794624
- OpenAlex
- W2767159911
- Cited by
- 85
- References
- 13
- Citations by year
- 2026: 3 · 2025: 15 · 2024: 9 · 2023: 8 · 2022: 12 · 2021: 13 · 2020: 10 · 2019: 7 · 2018: 8
- FWCI
- 8.90
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Psychiatric Services (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (T32MH019934)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- benzodiazepines, non-benzodiazepine hypnotics, chronic drug administration, sleep medication use, temporal trends, prescription drug use, NHANES, adverse drug outcomes
- MeSH terms
- Adolescent, Adult, Aged, Benzodiazepines, Drug Utilization, Female, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Nutrition Surveys, Drug Prescriptions, United States, Logistic Models, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.